https://www.fool.com/investing/small-cap/2010/08/12/impax-laboratories-magic-formula.aspx
https://www.fool.com/investing/high-growth/2010/08/27/how-long-can-salix-pharmaceuticals-last.aspx
https://www.fool.com/investing/general/2012/12/11/the-biggest-opportunities-for-nokia-investors.aspx
https://www.fool.com/2012/09/10/microsoft-and-nokia-unveil-devices-running-windows.aspx
https://www.fool.com/investing/general/2012/04/18/should-google-pay-a-dividend.aspx
https://www.fool.com/investing/general/2012/04/20/3-stocks-that-will-double-your-money.aspx
https://www.fool.com/investing/general/2012/12/19/the-walls-at-castle-microsoft-have-been-breached.aspx
https://www.fool.com/investing/general/2012/04/09/blue-chips-paying-5.aspx
https://www.fool.com/investing/general/2012/04/19/the-light-at-the-end-of-nokias-tunnel.aspx
https://www.fool.com/investing/general/2012/04/09/stock-tips-from-bill-gross.aspx
https://www.fool.com/investing/general/2013/01/25/splitting-bananas-and-fending-off-foreign-fruit.aspx
https://www.fool.com/investing/general/2012/03/19/dividends-with-an-extra-kick.aspx
https://www.fool.com/investing/high-growth/2010/08/18/interested-in-elan-start-here.aspx
https://www.fool.com/investing/general/2013/03/12/our-top-2-stocks-nordstrom-and-coach.aspx
https://www.fool.com/investing/general/2012/04/14/its-time-to-double-down-on-this-stock.aspx
https://www.fool.com/investing/general/2012/05/31/amazon-still-playing-catch-up-in-video.aspx
https://www.fool.com/investing/general/2012/02/24/blue-chips-paying-5.aspx
https://www.fool.com/investing/high-growth/2010/08/17/how-long-can-amylin-pharmaceuticals-last.aspx
https://www.fool.com/investing/general/2013/01/03/why-buy-nokia-3-reasons.aspx
https://www.fool.com/investing/general/2012/02/27/stock-of-the-week.aspx
https://www.fool.com/investing/general/2012/04/24/apple-has-a-target-on-its-back.aspx
https://www.fool.com/investing/general/2013/08/17/coach-is-the-stock-to-buy-in-august-heres-why.aspx
https://www.fool.com/investing/general/2013/10/17/3-health-care-stocks-to-watch-today.aspx
https://www.fool.com/investing/value/2011/03/08/elephant-hunting-4-companies-berkshire-could-buy.aspx
https://www.fool.com/investing/general/2012/04/16/buy-sell-or-hold-these-dow-stocks.aspx
https://www.fool.com/investing/general/2012/04/18/earnings-review-at-a-glance-yahoo.aspx
https://www.fool.com/investing/value/2011/03/14/bridgepoint-education-is-tarred-and-feathered.aspx
https://www.fool.com/2013/02/07/microsoft-delivers-record-q2-revenue.aspx
https://www.fool.com/investing/general/2010/08/16/dominos-magic-formula.aspx
https://www.fool.com/investing/dividends-income/2010/08/18/insiders-are-buying-dean-foods-should-you.aspx
https://www.fool.com/investing/general/2012/03/19/this-tech-turnaround-is-our-stock-of-the-week.aspx
https://www.fool.com/investing/general/2010/08/16/bridgepoint-educations-magic-formula.aspx
https://www.fool.com/investing/high-growth/2010/08/24/will-valeant-pharmaceuticals-burn-you.aspx
https://www.fool.com/investing/general/2010/08/16/insiders-are-buying-stein-mart-should-you.aspx
https://www.fool.com/2013/02/07/nokias-turnaround-in-progress.aspx
https://www.fool.com/investing/general/2013/10/17/how-to-find-winners-in-the-biotech-space.aspx
https://www.fool.com/investing/general/2010/08/18/insiders-are-buying-dole-food-should-you.aspx
https://www.fool.com/investing/general/2012/05/31/is-it-time-to-buy-chesapeake.aspx
https://www.fool.com/investing/general/2012/12/10/how-microsofts-opportunities-in-the-living-room-ca.aspx
https://www.fool.com/investing/general/2010/08/27/the-most-important-thing-about-regeneron-pharmaceu.aspx
https://www.fool.com/investing/general/2012/04/20/what-really-matters-for-yahoo.aspx
https://www.fool.com/investing/general/2012/04/25/this-stock-is-smokin.aspx
https://www.fool.com/investing/general/2013/08/16/yet-another-retailer-struggles-with-consumer-spend.aspx
https://www.fool.com/investing/high-growth/2010/08/17/interested-in-cephalon-start-here.aspx
https://www.fool.com/investing/general/2012/04/20/the-no-1-nuclear-stock.aspx
https://www.fool.com/investing/general/2012/02/24/the-real-winners-in-streaming.aspx
https://www.fool.com/investing/general/2010/08/16/insiders-are-buying-dpl-should-you.aspx
https://www.fool.com/investing/2016/11/05/how-thinking-globally-can-boost-your-portfolio.aspx
https://www.fool.com/investing/general/2012/02/22/this-company-puts-money-in-your-pocket.aspx
https://www.fool.com/investing/high-growth/2010/08/18/dendreons-big-pharma-future.aspx
https://www.fool.com/investing/high-growth/2010/08/18/the-most-important-thing-about-human-genome-scienc.aspx
https://www.fool.com/investing/general/2012/12/20/can-nokia-speed-up-the-clock.aspx
https://www.fool.com/investing/general/2012/04/18/does-the-apple-bear-case-hold-up.aspx
https://www.fool.com/investing/general/2012/02/26/stock-of-the-week.aspx
https://www.fool.com/investing/general/2010/08/16/renaissance-learnings-magic-formula.aspx
https://www.fool.com/investing/general/2012/04/09/why-exelon-is-our-stock-of-the-week.aspx
https://www.fool.com/investing/general/2014/01/21/the-best-ceo-of-2013-elon-musk-or-mark-zuckerberg.aspx
https://www.fool.com/investing/general/2013/08/13/yum-cant-shake-its-trouble-in-china.aspx
https://www.fool.com/investing/general/2012/02/22/dog-of-the-week.aspx
https://www.fool.com/investing/general/2010/08/18/will-united-therapeutics-burn-you.aspx
https://www.fool.com/retirement/iras/2012/04/10/top-10-stocks-for-your-ira-novartis.aspx
https://www.fool.com/investing/general/2012/03/26/is-it-too-late-to-buy-big-oil.aspx
https://www.fool.com/investing/general/2011/03/02/who-deserves-your-business.aspx
https://www.fool.com/investing/general/2011/04/20/are-these-the-rights-youre-looking-for.aspx
https://www.fool.com/investing/general/2012/03/09/why-gms-in-our-doghouse.aspx
https://www.fool.com/investing/general/2010/08/16/select-comforts-magic-formula.aspx
https://www.fool.com/investing/general/2010/08/16/insiders-are-buying-cabelas-should-you.aspx
https://www.fool.com/investing/general/2012/04/16/the-highest-yielding-stocks-you-can-buy-today.aspx
https://www.fool.com/investing/general/2012/04/27/is-now-the-time-to-buy-baidu.aspx
https://www.fool.com/investing/general/2014/01/25/stocks-to-watch-in-2014-twitter-intel-and-bank-of.aspx
https://www.fool.com/investing/general/2012/04/20/microsofts-outlook-trumps-current-earnings.aspx
https://www.fool.com/investing/general/2010/08/18/will-endo-pharmaceuticals-holdings-burn-you.aspx
https://www.fool.com/investing/2018/03/12/will-you-actually-eat-at-the-restaurant-of-tomorro.aspx
https://www.fool.com/investing/general/2012/12/22/how-to-really-understand-microsoft-share-prices.aspx
https://www.fool.com/investing/dividends-income/2010/08/23/lorillards-magic-formula.aspx
https://www.fool.com/investing/general/2010/08/12/agilents-magic-formula.aspx
https://www.fool.com/investing/high-growth/2010/09/10/todays-buy-opportunity-take-two-interactive.aspx
https://www.fool.com/investing/general/2012/03/09/buy-sell-or-hold-large-cap-edition.aspx
https://www.fool.com/investing/general/2010/08/17/insiders-are-buying-calumet-specialty-products-sho.aspx
https://www.fool.com/retirement/iras/2012/04/14/top-10-stocks-for-your-ira-johnson.aspx
https://www.fool.com/investing/high-growth/2010/08/17/how-long-can-biovail-last.aspx
https://www.fool.com/investing/general/2012/12/16/how-youll-know-its-time-to-sell-microsoft-3-signs.aspx
https://www.fool.com/2012/10/24/msft-cautious-optimism-for-microsofts-future.aspx
https://www.fool.com/investing/general/2012/02/17/this-tech-stock-is-making-a-comeback.aspx
https://www.fool.com/investing/high-growth/2010/08/18/will-dendreon-burn-you.aspx
https://www.fool.com/investing/high-growth/2011/03/14/buying-opportunities-in-for-profit-education.aspx
https://www.fool.com/investing/general/2012/12/13/3-reasons-why-buying-microsoft-could-make-you-mone.aspx
https://www.fool.com/investing/general/2010/08/16/insiders-are-buying-pep-boys-should-you.aspx
https://www.fool.com/investing/general/2012/04/25/its-not-too-late-to-buy-microsoft.aspx
https://www.fool.com/investing/general/2013/02/06/ask-a-fool-lighting-a-fire-under-big-tobacco.aspx
https://www.fool.com/investing/general/2012/12/14/why-sell-nokia-3-things-to-consider.aspx
https://www.fool.com/investing/high-growth/2010/08/17/is-alexion-pharmaceuticals-burning-out.aspx
https://www.fool.com/investing/general/2010/10/21/simple-lessons-from-an-investing-genius.aspx
https://www.fool.com/investing/general/2012/04/21/this-stock-is-fashionably-cheap.aspx
https://www.fool.com/investing/general/2012/03/19/the-chinese-stock-you-have-to-own.aspx
https://www.fool.com/investing/high-growth/2010/08/26/will-biomarin-pharmaceutical-burn-you.aspx
https://www.fool.com/investing/general/2012/03/26/will-brazils-oil-gambit-backfire.aspx
https://www.fool.com/investing/general/2012/03/09/five-dividends-that-cant-be-beat.aspx
https://www.fool.com/investing/general/2012/04/20/4-stocks-for-a-diversified-portfolio.aspx
https://www.fool.com/investing/small-cap/2010/08/26/will-onyx-pharmaceuticals-burn-you.aspx
